Sildenafil vs Avanafil: How Viagra and Stendra Compare
Viagra and Stendra side by side: timing, dose, food, side effects and the pooled evidence.
Sponsored
Sildenafil (Viagra) and avanafil (Stendra) are both FDA-approved ED tablets, and the main practical difference is timing. The Stendra label says to take it as early as about 15 minutes before sexual activity, while the Viagra label says about 1 hour, with a window of 30 minutes to 4 hours.21 Across several network meta-analyses of placebo-controlled trials, sildenafil ranked as more effective than avanafil, while avanafil's label side effect rates are lower than sildenafil's, though those come from different trials.345 This guide sets the two labels and the pooled evidence side by side.
How do sildenafil and avanafil differ on the label?
| Sildenafil (Viagra) | Avanafil (Stendra) | |
|---|---|---|
| Starting dose | 50 mg; may go to 100 mg or down to 25 mg2 | 100 mg; may go to 200 mg or down to 50 mg1 |
| Timing before sex | About 1 hour; 30 minutes to 4 hours2 | As early as about 15 minutes (100 or 200 mg); about 30 minutes for 50 mg1 |
| Time to peak blood level (fasted) | 30 to 120 minutes, median 602 | Median 30 to 45 minutes1 |
| Terminal half-life | About 4 hours2 | About 5 hours1 |
| High-fat meal | Absorption delayed by 60 minutes on average; peak level 29% lower2 | Peak delayed by about 1.1 to 1.25 hours; peak level 39% lower, total exposure about 4% lower; label says take with or without food1 |
| Maximum frequency | Once per day2 | Once per day1 |
| Nitrates | Contraindicated in any form2 | Contraindicated in any form1 |
Both labels say sexual stimulation is needed for a response.21 Neither label states how long the effect lasts. The half-life figures describe how fast the drug leaves the blood, not how long an erection response continues.
Which is more effective, sildenafil or avanafil?
No head-to-head trial is in our sources, so the comparison comes from network meta-analyses, which link drugs through their placebo comparisons. Four published analyses point the same way:
- A 2013 analysis of 118 trials (31,195 men) found avanafil less effective than tadalafil and vardenafil on a global assessment question, and found no major safety difference between the agents.6
- A 2015 trade-off analysis of 82 trials (47,626 men) found that sildenafil 50 mg had the greatest efficacy but also the highest rate of overall adverse events, while avanafil 100 mg had similar overall adverse events to sildenafil 50 mg with a markedly lower global efficacy.3
- A 2021 analysis of 179 trials (50,620 men) ranked sildenafil 25 mg and 50 mg highest for the erectile function score and described avanafil as a less effective intervention.4
- A 2026 dose-specific analysis of 83 studies (6,029 men) found odds ratios against placebo for reaching a satisfactory erectile function score of 7.90 for sildenafil 50 mg and 9.06 for 100 mg, against 1.75 for avanafil 100 mg and 3.42 for 200 mg. Two of its authors work for Viatris, a company that sells sildenafil.5
Pooled results are averages. A man who has not responded to one tablet may respond to another, and a drug ranked lower on average can still be the better fit for a particular person. The pooled evidence does not mean avanafil does not help: it is approved on the strength of its own placebo-controlled trials.1
What do the placebo-controlled trials of each drug show?
The Stendra label reports a 646-man, 3-month trial in the general ED population. On the erectile function score, the change from baseline was 2.9 on placebo, 5.4 on 50 mg, 8.3 on 100 mg and 9.5 on 200 mg, and the share of attempts ending in successful intercourse at the end of treatment was 27.0% on placebo against 41.3%, 57.1% and 57.0%.1 A separate 435-man trial measured time to onset of effect, with doses taken about 15 minutes before sexual activity.1
The Viagra label reports diary data from two studies (178 men) in which successful intercourse per attempt was 70% on sildenafil and 29% on placebo.2 Because the trials used different designs, populations and measures, those figures should not be read as a score for each drug. They show that each beat placebo in its own program.
How do their side effects compare?
The labels report side effects from different trials, so the numbers below describe each program rather than a direct contest.
| Side effect | Sildenafil, flexible dose (n=734) vs placebo (n=725)2 | Avanafil 100 mg (n=349) and 200 mg (n=352) vs placebo (n=349)1 |
|---|---|---|
| Headache | 16% vs 4% | 6.9% and 10.5% vs 1.7% |
| Flushing | 10% vs 1% | 4.3% and 4.0% vs 0.0% |
| Nasal congestion | 4% vs 2% | 2.9% and 2.0% vs 1.1% |
| Indigestion | 7% vs 2% | Not listed at 2% or more |
| Abnormal vision | 3% vs 0% | One subject across all trials reported a color vision change |
Lower percentages for avanafil fit the 2015 finding that avanafil 100 mg is comparable to sildenafil 50 mg on overall adverse events in pooled data, and the 2013 finding of no major safety difference, so the labels alone do not show that one is safer.36 Both drugs carry the same class warnings, including priapism, sudden vision or hearing loss, and a drop in blood pressure.21
When might each one be the better fit?
These are questions to put to a prescriber, not recommendations.
- Short notice. Avanafil's label allows dosing as early as about 15 minutes ahead, which suits men who want less planning time. A faster time to peak is not the same as a better result in every man.1
- Food. Both labels say the tablet can be taken with or without food, but the sildenafil label notes slower absorption after a high-fat meal.21 Our guide to which ED medication suits which situation covers meals and timing across all four drugs.
- Interactions. The Stendra label says not to use it with strong CYP3A4 inhibitors and to cap it at 50 mg with moderate inhibitors; the Viagra label recommends 25 mg with ritonavir and consideration of a 25 mg start with other strong inhibitors.21
- Alpha-blockers. The Stendra label says to start at 50 mg in men on stable alpha-blocker therapy; the Viagra label says to start at 25 mg.21
- Age, kidney and liver disease. The Viagra label says to consider a 25 mg start in men over 65, with any liver impairment or with severe kidney impairment. The Stendra label needs no adjustment for age alone or for mild to moderate kidney or liver impairment, and says not to use it in severe kidney or liver disease.21
Our pick: Quattro from Vea Health Sponsored
Quattro is our pick in this guide because we have a financial relationship with Vea Health. That is the basis for the placement, not a test or a trial result, and we make no claim that it is faster, stronger or safer than sildenafil, avanafil or any other option.
Vea Health describes Quattro as a compounded sublingual dose combining sildenafil, tadalafil, vardenafil and apomorphine, prescribed only after a licensed clinician reviews a health history.7 It contains neither avanafil nor a single drug, so it is a different kind of product from either tablet above. It is not FDA-approved, and the FDA says it does not verify the safety, effectiveness or quality of compounded drugs before they reach patients.8 Both the Viagra and Stendra labels contraindicate nitrates, and each describes only its own drug, so those labels do not tell a reader how a multi-drug dose behaves.21 The page we loaded does not list strengths. Quattro suits a man who has discussed a multi-drug dissolving format with a clinician and accepts that it is compounded. Our guide to sublingual versus swallowed ED treatments covers the format difference.
What should you ask before choosing?
- Is the product FDA-approved or compounded? See compounded versus FDA-approved ED medications.
- Which starting strength suits my other medicines, especially nitrates, alpha-blockers and anything that affects CYP3A4?
- If the first tablet is not enough, would a different drug be tried before a higher dose? Our four-way comparison of the ED pills and the pairing of sildenafil and vardenafil cover the other options.
- Is a daily or as-needed schedule more suitable? See daily versus as-needed tadalafil.
Safety information
Sildenafil and avanafil must never be taken with nitrates in any form. An erection lasting more than four hours needs emergency care, as does sudden vision or hearing loss.21 Only a licensed clinician who knows your history and medicines can say whether any ED medication is appropriate.
Frequently asked questions
Is avanafil better than sildenafil?
Not on average in pooled trial data. Network meta-analyses ranked sildenafil above avanafil for efficacy, while the Stendra label allows dosing about 15 minutes ahead against about an hour for Viagra. No head-to-head trial is in our sources.
Which works faster, sildenafil or avanafil?
Avanafil's label gives a median time to peak level of 30 to 45 minutes and allows dosing as early as about 15 minutes ahead. Sildenafil's label gives a median of 60 minutes and advises about 1 hour. Time to peak level is not a guarantee of a response.
Does avanafil have fewer side effects than sildenafil?
Its label rates are lower (headache 6.9% to 10.5% against 16%), but they come from different trials. A 2015 pooled analysis found avanafil 100 mg had similar overall adverse events to sildenafil 50 mg.
Can you take sildenafil and avanafil together?
Neither label recommends it. Each describes only its own drug, and both contraindicate nitrates. A clinician has to decide whether any ED medication, alone or with another, is safe for you.
More comparisons
Part of our guide: ED Pills Compared: Sildenafil, Tadalafil, Vardenafil and Avanafil
Sources
- Metuchen Pharmaceuticals. STENDRA (avanafil) prescribing information. DailyMed, U.S. National Library of Medicine.
- Pfizer. VIAGRA (sildenafil citrate) prescribing information. DailyMed, U.S. National Library of Medicine.
- Chen L, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015. PubMed 25817916.
- Madeira CR, et al. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis. World J Urol. 2021. PubMed 32388784.
- Salonia A, et al. A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials. J Sex Med. 2026. PubMed 42296271.
- Yuan J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013. PubMed 23395275.
- Vea Health. Quattro. Accessed October 22, 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Eli Lilly. CIALIS (tadalafil) prescribing information. DailyMed, U.S. National Library of Medicine.
- Dula E, et al. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol. 2001. PubMed 11464037.